{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:46:10Z","timestamp":1792403170631,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The natural product carolacton is a macrolide keto-carboxylic acid produced by the myxobacterium\n                    <jats:italic>Sorangium cellulosum<\/jats:italic>\n                    , and was originally described as an antibacterial compound. Here we show that carolacton targets FolD, a key enzyme from the folate-dependent C1 metabolism. We characterize the interaction between bacterial FolD and carolacton biophysically, structurally and biochemically. Carolacton binds FolD with nanomolar affinity, and the crystal structure of the FolD\u2013carolacton complex reveals the mode of binding. We show that the human FolD orthologs, MTHFD1 and MTHFD2, are also inhibited in the low nM range, and that micromolar concentrations of carolacton inhibit the growth of cancer cell lines. As mitochondrial MTHFD2 is known to be upregulated in cancer cells, it may be possible to use carolacton as an inhibitor tool compound to assess MTHFD2 as an anti-cancer target.\n                  <\/jats:p>","DOI":"10.1038\/s41467-017-01671-5","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T05:20:55Z","timestamp":1510291255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["The natural product carolacton inhibits folate-dependent C1 metabolism by targeting FolD\/MTHFD"],"prefix":"10.1038","volume":"8","author":[{"given":"Chengzhang","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asfandyar","family":"Sikandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1115-8714","authenticated-orcid":false,"given":"Jannik","family":"Donner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor","family":"Zaburannyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Reck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Wagner-D\u00f6bler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7153-1365","authenticated-orcid":false,"given":"Jesko","family":"Koehnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"key":"1671_CR1","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","volume":"1830","author":"GM Cragg","year":"2013","unstructured":"Cragg, G. M. & Newman, D. J. Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta 1830, 3670\u20133695 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"1671_CR2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/ejoc.200901126","volume":"2010","author":"R Jansen","year":"2010","unstructured":"Jansen, R. et al. Carolacton-a macrolide ketocarbonic acid that reduces biofilm formation by the caries- and endocarditis-associated bacterium Streptococcus mutans. Eur. J. Org. Chem. 2010, 1284\u20131289 (2010).","journal-title":"Eur. J. Org. Chem."},{"key":"1671_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/srep29677","volume":"6","author":"J Donner","year":"2016","unstructured":"Donner, J. et al. The biofilm inhibitor Carolacton inhibits planktonic growth of virulent pneumococci via a conserved target. Sci. Rep. 6, 29677 (2016).","journal-title":"Sci. Rep."},{"key":"1671_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1471-2180-10-199","volume":"10","author":"B Kunze","year":"2010","unstructured":"Kunze, B. et al. Damage of Streptococcus mutans biofilms by carolacton, a secondary metabolite from the myxobacterium Sorangium cellulosum. BMC Microbiol. 10, 199 (2010).","journal-title":"BMC Microbiol."},{"key":"1671_CR5","doi-asserted-by":"publisher","unstructured":"Green, J. M. & Matthews, R. G. Folate biosynthesis, reduction, and polyglutamylation and the interconversion of folate derivatives. EcoSal Plus 2, doi:10.1128\/ecosalplus.3.6.3.6 (2007).","DOI":"10.1128\/ecosalplus.3.6.3.6"},{"key":"1671_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker, G. S. & Rabinowitz, J. D. One-carbon metabolism in health and disease. Cell. Metab. 25, 27\u201342 (2017).","journal-title":"Cell. Metab."},{"key":"1671_CR7","volume-title":"Folates and Pterins","author":"RL Blakley","year":"1984","unstructured":"Blakley, R. L., Benkovic, S. J. & Whitehead, V. M. Folates and Pterins (Wiley, New York, Chichester, 1984)."},{"key":"1671_CR8","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1096\/fasebj.5.12.1916088","volume":"5","author":"DR Appling","year":"1991","unstructured":"Appling, D. R. Compartmentation of folate-mediated one-carbon metabolism in eukaryotes. FASEB J. 5, 2645\u20132651 (1991).","journal-title":"FASEB J."},{"key":"1671_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/bies.20420","volume":"28","author":"KE Christensen","year":"2006","unstructured":"Christensen, K. E. & MacKenzie, R. E. Mitochondrial one-carbon metabolism is adapted to the specific needs of yeast, plants and mammals. Bioessays 28, 595\u2013605 (2006).","journal-title":"Bioessays"},{"key":"1671_CR10","doi-asserted-by":"crossref","unstructured":"Christensen, K. E. & MacKenzie, R. E. in Folic Acid and Folates (Gerald L., editor), pp. 393\u2013410 (Academic Press, 2008).","DOI":"10.1016\/S0083-6729(08)00414-7"},{"key":"1671_CR11","doi-asserted-by":"publisher","first-page":"13481","DOI":"10.1073\/pnas.172501499","volume":"99","author":"PTR Rajagopalan","year":"2002","unstructured":"Rajagopalan, P. T. R. et al. Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics. Proc. Natl Acad. Sci. USA 99, 13481\u201313486 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1671_CR12","doi-asserted-by":"publisher","first-page":"e35973","DOI":"10.1371\/journal.pone.0035973","volume":"7","author":"TC Eadsforth","year":"2012","unstructured":"Eadsforth, T. C. et al. Assessment of Pseudomonas aeruginosa N5,N10-methylenetetrahydrofolate dehydrogenase-cyclohydrolase as a potential antibacterial drug target. PLoS ONE 7, e35973 (2012).","journal-title":"PLoS ONE"},{"key":"1671_CR13","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1111\/febs.12025","volume":"279","author":"TC Eadsforth","year":"2012","unstructured":"Eadsforth, T. C., Maluf, F. V. & Hunter, W. N. Acinetobacter baumannii FolD ligand complexes --potent inhibitors of folate metabolism and a re-evaluation of the structure of LY374571. FEBS J. 279, 4350\u20134360 (2012).","journal-title":"FEBS J."},{"key":"1671_CR14","doi-asserted-by":"publisher","first-page":"7938","DOI":"10.1021\/acs.jmedchem.5b00687","volume":"58","author":"TC Eadsforth","year":"2015","unstructured":"Eadsforth, T. C. et al. Characterization of 2,4-diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido based inhibitors of trypanosoma brucei FolD and testing for antiparasitic activity. J. Med. Chem. 58, 7938\u20137948 (2015).","journal-title":"J. Med. Chem."},{"key":"1671_CR15","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1021\/bi992734y","volume":"39","author":"A Schmidt","year":"2000","unstructured":"Schmidt, A. et al. Structures of three inhibitor complexes provide insight into the reaction mechanism of the human methylenetetrahydrofolate dehydrogenase\/cyclohydrolase. Biochemistry 39, 6325\u20136335 (2000).","journal-title":"Biochemistry"},{"key":"1671_CR16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3565(24)37793-6","volume":"287","author":"JL Tonkinson","year":"1998","unstructured":"Tonkinson, J. L. et al. The antiproliferative and cell cycle effects of 5,6,7, 8-tetrahydro-N5,N10-carbonylfolic acid, an inhibitor of methylenetetrahydrofolate dehydrogenase, are potentiated by hypoxanthine. J. Pharmacol. Exp. Ther. 287, 315\u2013321 (1998).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1671_CR17","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1158\/0008-5472.CAN-16-1476","volume":"77","author":"R Gustafsson","year":"2017","unstructured":"Gustafsson, R. et al. Crystal structure of the emerging cancer target MTHFD2 in complex with a substrate-based inhibitor. Cancer Res. 77, 937\u2013948 (2017).","journal-title":"Cancer Res."},{"key":"1671_CR18","first-page":"605","volume":"4","author":"AC McDonald","year":"1998","unstructured":"McDonald, A. C. et al. A phase I and pharmacokinetic study of LY231514, the multitargeted antifolate. Clin. Cancer Res. 4, 605\u2013610 (1998).","journal-title":"Clin. Cancer Res."},{"key":"1671_CR19","first-page":"1116","volume":"57","author":"C Shih","year":"1997","unstructured":"Shih, C. et al. LY231514, apyrrolo2,3-dpyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. Cancer Res. 57, 1116\u20131123 (1997).","journal-title":"Cancer Res."},{"key":"1671_CR20","volume":"5","author":"R Nilsson","year":"2014","unstructured":"Nilsson, R. et al. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat. Commun. 5, 3128 (2014).","journal-title":"Nat. Commun."},{"key":"1671_CR21","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1158\/1541-7786.MCR-15-0117","volume":"13","author":"PM Tedeschi","year":"2015","unstructured":"Tedeschi, P. M., Vazquez, A., Kerrigan, J. E. & Bertino, J. R. Mitochondrial methylenetetrahydrofolate dehydrogenase (MTHFD2) overexpression is associated with tumor cell proliferation and is a novel target for drug development. Mol. Cancer Res. 13, 1361\u20131366 (2015).","journal-title":"Mol. Cancer Res."},{"key":"1671_CR22","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1016\/S0021-9258(18)34857-9","volume":"257","author":"JE Clark","year":"1982","unstructured":"Clark, J. E. & Ljungdahl, L. G. Purification and properties of 5,10-methenyltetrahydrofolate cyclohydrolase from Clostridium formicoaceticum. J. Biol. Chem. 257, 3833\u20133836 (1982).","journal-title":"J. Biol. Chem."},{"key":"1671_CR23","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1128\/jb.173.4.1414-1419.1991","volume":"173","author":"G Wohlfarth","year":"1991","unstructured":"Wohlfarth, G., Geerligs, G. & Diekert, G. Purification and characterization of NADP(+)-dependent 5,10-methylenetetrahydrofolate dehydrogenase from Peptostreptococcus productus marburg. J. Bacteriol. 173, 1414\u20131419 (1991).","journal-title":"J. Bacteriol."},{"key":"1671_CR24","doi-asserted-by":"crossref","first-page":"23953","DOI":"10.1016\/S0021-9258(18)54377-5","volume":"266","author":"L D\u2019Ari","year":"1991","unstructured":"D\u2019Ari, L. & Rabinowitz, J. C. Purification, characterization, cloning, and amino acid sequence of the bifunctional enzyme 5,10-methylenetetrahydrofolate dehydrogenase\/5,10-methenyltetrahydrofolate cyclohydrolase from Escherichia coli. J. Biol. Chem. 266, 23953\u201323958 (1991).","journal-title":"J. Biol. Chem."},{"key":"1671_CR25","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1021\/acs.biochem.5b00400","volume":"54","author":"S Sah","year":"2015","unstructured":"Sah, S. & Varshney, U. Impact of mutating the key residues of a bifunctional 5,10-methylenetetrahydrofolate dehydrogenase-cyclohydrolase from Escherichia coli on its activities. Biochemistry 54, 3504\u20133513 (2015).","journal-title":"Biochemistry"},{"key":"1671_CR26","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1016\/S0021-9258(17)34711-7","volume":"253","author":"IK Dev","year":"1978","unstructured":"Dev, I. K. & Harvey, R. J. A complex of N5,N10-methylenetetrahydrofolate dehydrogenase and N5,N10-methenyltetrahydrofolate cyclohydrolase in Escherichia coli. Purification, subunit structure, and allosteric inhibition by N10-formyltetrahydrofolate. J. Biol. Chem. 253, 4245\u20134253 (1978).","journal-title":"J. Biol. Chem."},{"key":"1671_CR27","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1110\/ps.8.6.1342","volume":"8","author":"BW Shen","year":"1999","unstructured":"Shen, B. W. et al. The crystal structure of a bacterial, bifunctional 5,10 methylene-tetrahydrofolate dehydrogenase\/cyclohydrolase. Protein Sci. 8, 1342\u20131349 (1999).","journal-title":"Protein Sci."},{"key":"1671_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0969-2126(98)00019-7","volume":"6","author":"M Allaire","year":"1998","unstructured":"Allaire, M., Li, Y., MacKenzie, R. E. & Cygler, M. The 3-D structure of a folate-dependent dehydrogenase\/cyclohydrolase bifunctional enzyme at 1.5 A resolution. Structure 6, 173\u2013182 (1998).","journal-title":"Structure"},{"key":"1671_CR29","doi-asserted-by":"crossref","unstructured":"Solinski, A. E. et al. Diverted total synthesis of carolacton-inspired analogs yields three distinct phenotypes in streptococcus mutans biofilms. J. Am. Chem. Soc. 139, 7188\u20137191 (2017).","DOI":"10.1021\/jacs.7b03879"},{"key":"1671_CR30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1042\/bj3500609","volume":"350","author":"BEH Maden","year":"2000","unstructured":"Maden, B. E. H. Tetrahydrofolate and tetrahydromethanopterin compared. Functionally distinct carriers in C1 metabolism. Biochem. J. 350, 609\u2013629 (2000).","journal-title":"Biochem. J."},{"key":"1671_CR31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1128\/JB.02365-14","volume":"197","author":"S Sah","year":"2015","unstructured":"Sah, S., Aluri, S., Rex, K. & Varshney, U. One-carbon metabolic pathway rewiring in Escherichia coli reveals an evolutionary advantage of 10-formyltetrahydrofolate synthetase (Fhs) in survival under hypoxia. J. Bacteriol. 197, 717\u2013726 (2015).","journal-title":"J. Bacteriol."},{"key":"1671_CR32","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1128\/jb.179.5.1563-1572.1997","volume":"179","author":"PJ Crowley","year":"1997","unstructured":"Crowley, P. J., Gutierrez, J. A., Hillman, J. D. & Bleiweis, A. S. Genetic and physiologic analysis of a formyl-tetrahydrofolate synthetase mutant of Streptococcus mutans. J. Bacteriol. 179, 1563\u20131572 (1997).","journal-title":"J. Bacteriol."},{"key":"1671_CR33","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.4049\/jimmunol.132.5.2582","volume":"132","author":"M Vaara","year":"1984","unstructured":"Vaara, M., Viljanen, P., Vaara, T. & M\u00e4kel\u00e4, P. H. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action. J. Immunol. 132, 2582\u20132589 (1984).","journal-title":"J. Immunol."},{"key":"1671_CR34","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1021\/jm9904598","volume":"42","author":"TE Renau","year":"1999","unstructured":"Renau, T. E. et al. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J. Med. Chem. 42, 4928\u20134931 (1999).","journal-title":"J. Med. Chem."},{"key":"1671_CR35","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1073\/pnas.87.12.4645","volume":"87","author":"SG Grant","year":"1990","unstructured":"Grant, S. G., Jessee, J., Bloom, F. R. & Hanahan, D. Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants. Proc. Natl Acad. Sci. USA 87, 4645\u20134649 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1671_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pep.2008.09.008","volume":"63","author":"H Liu","year":"2009","unstructured":"Liu, H. & Naismith, J. H. A simple and efficient expression and purification system using two newly constructed vectors. Protein Expr. Purif. 63, 102\u2013111 (2009).","journal-title":"Protein Expr. Purif."},{"key":"1671_CR37","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","volume":"28","author":"M Kearse","year":"2012","unstructured":"Kearse, M. et al. Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28, 1647\u20131649 (2012).","journal-title":"Bioinformatics"},{"key":"1671_CR38","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1101\/gr.2289704","volume":"14","author":"ACE Darling","year":"2004","unstructured":"Darling, A. C. E., Mau, B., Blattner, F. R. & Perna, N. T. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 14, 1394\u20131403 (2004).","journal-title":"Genome Res."},{"key":"1671_CR39","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1126\/science.1061217","volume":"293","author":"H Tettelin","year":"2001","unstructured":"Tettelin, H. et al. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293, 498\u2013506 (2001).","journal-title":"Science"},{"key":"1671_CR40","doi-asserted-by":"crossref","unstructured":"M\u00fcller, R. et al. Discovery and total synthesis of natural cystobactamid derivatives with superior activity against Gram-negative pathogens. Angew. Chem. Int. Ed. 56, 12760\u201312764 (2017).","DOI":"10.1002\/anie.201705913"},{"key":"1671_CR41","doi-asserted-by":"publisher","first-page":"10113","DOI":"10.1002\/anie.201603288","volume":"55","author":"H Steinmetz","year":"2016","unstructured":"Steinmetz, H. et al. Isolation, structure elucidation, and (Bio)Synthesis of Haprolid, a cell-type-specific myxobacterial cytotoxin. Angew. Chem. Int. Ed. 55, 10113\u201310117 (2016).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1671_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1107\/S0021889809045701","volume":"43","author":"G Winter","year":"2010","unstructured":"Winter, G. xia2: an expert system for macromolecular crystallography data reduction. J. Appl. Crystallogr. 43, 186\u2013190 (2010).","journal-title":"J. Appl. Crystallogr."},{"key":"1671_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"1671_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"1671_CR45","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"1671_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"1671_CR47","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1107\/S0907444904019079","volume":"60","author":"P Skubak","year":"2004","unstructured":"Skubak, P., Murshudov, G. N. & Pannu, N. S. Direct incorporation of experimental phase information in model refinement. Acta Crystallogr. D Biol. Crystallogr. 60, 2196\u20132201 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"1671_CR48","unstructured":"The PyMOL Molecular Graphics System, Version 1.8.2.1 Schr\u00f6dinger, LLC."},{"key":"1671_CR49","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Model."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01671-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:36:00Z","timestamp":1750966560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01671-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1671"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-01671-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,16]]},"assertion":[{"value":"23 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1529"}}